Therapy (HAV)

HAV Vaccination More Effective Before Decompensation In Hepatic Disease

Published in Hepatitis Weekly, September 3rd, 2001

by Sonia Nichols, senior medical writer - Doctors are now recommending that patients with chronic liver disease receive hepatitis A virus (HAV) vaccines while they retain hepatic compensation. HAV vaccination after liver decompensation becomes apparent is not as effective, according to a U.S. study.

Although HAV vaccination is suggested for patients who have liver disease in order to avoid the increased risk of death or illness that could result from HAV infection, few studies have investigated the efficacy of vaccination in advanced, chronic liver disease sufferers, leaving doctors with very little information about immunological responsiveness in those patients,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2001-09-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry